Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Almotriptan and Topiramate for Medication Overuse Headache
NCT00432549Phase 4Unknown
- Sponsor
- The New England Center for Headache
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of almotriptan and topiramate in medication overuse headache (MOH), sponsored by The New England Center for Headache. Primary endpoints: Primary measure for the detoxification period at 2 weeks and Number of days with mild or no pain in the first two weeks of treatment at 2 weeks. Status: unknown.
02
Drugs
almotriptantopiramate
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on NCT00432549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432549.